litlas
ログインアカウント作成

Mark J. Smyth

1990–2022 年に発表

359
論文数
111,096
被引用数
172
h 指数
359
i10 指数

被引用数

Mark J. Smyth の年別被引用数1905 年: 被引用 2 件1945 年: 被引用 1 件1971 年: 被引用 2 件1978 年: 被引用 1 件1979 年: 被引用 2 件1990 年: 被引用 2 件1991 年: 被引用 11 件1992 年: 被引用 12 件1993 年: 被引用 14 件1994 年: 被引用 18 件1995 年: 被引用 28 件1996 年: 被引用 40 件1997 年: 被引用 35 件1998 年: 被引用 33 件1999 年: 被引用 73 件2000 年: 被引用 125 件2001 年: 被引用 210 件2002 年: 被引用 388 件2003 年: 被引用 443 件2004 年: 被引用 591 件2005 年: 被引用 630 件2006 年: 被引用 605 件2007 年: 被引用 706 件2008 年: 被引用 751 件2009 年: 被引用 719 件2010 年: 被引用 812 件2011 年: 被引用 867 件2012 年: 被引用 982 件2013 年: 被引用 1,164 件2014 年: 被引用 1,114 件2015 年: 被引用 1,629 件2016 年: 被引用 1,757 件2017 年: 被引用 1,985 件2018 年: 被引用 1,890 件2019 年: 被引用 4,817 件2020 年: 被引用 5,768 件2021 年: 被引用 5,611 件2022 年: 被引用 4,406 件2023 年: 被引用 3,340 件2024 年: 被引用 4,064 件2025 年: 被引用 1,945 件2026 年: 被引用 42 件1906〜1944 年は被引用が無いため表示していません1946〜1970 年は被引用が無いため表示していません1972〜1977 年は被引用が無いため表示していません1980〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 11,443 件、この内訳の 25.4%中国: 引用元論文 7,713 件、この内訳の 17.1%ドイツ: 引用元論文 2,380 件、この内訳の 5.3%フランス: 引用元論文 2,033 件、この内訳の 4.5%イギリス: 引用元論文 2,026 件、この内訳の 4.5%イタリア: 引用元論文 2,005 件、この内訳の 4.4%オーストラリア: 引用元論文 1,871 件、この内訳の 4.1%日本: 引用元論文 1,523 件、この内訳の 3.4%カナダ: 引用元論文 1,216 件、この内訳の 2.7%スペイン: 引用元論文 955 件、この内訳の 2.1%オランダ: 引用元論文 937 件、この内訳の 2.1%スイス: 引用元論文 809 件、この内訳の 1.8%
0%25.4%その他 22.6%

機関

分野

  • Medicine41.7%
  • Immunology and Microbiology31.9%
  • Biochemistry, Genetics and Molecular Biology20.8%
  • Engineering2.5%
  • Neuroscience0.8%
  • Materials Science0.5%
  • その他1.8%

トピック

  • Immune Cell Function and Interaction9.8%
  • Cancer Immunotherapy and Biomarkers9.1%
  • Immunotherapy and Immune Responses7.1%
  • CAR-T cell therapy research5.1%
  • T-cell and B-cell Immunology4.3%
  • Immune cells in cancer4%
  • その他60.6%

共著者

全論文

検索で開く
  1. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

    著者: Robert D. Schreiber, Lloyd J. Old, Mark J. Smyth - Science 2011 被引用: 6,463

  2. Cancer immunoediting and resistance to T cell-based immunotherapy

    著者: Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth - Nature Reviews Clinical Oncology 2018 被引用: 1,789

  3. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    著者: Lorenzo Galluzzi, Ilio Vitale, Sarah H. Warren, Sandy Adjemian, Patrizia Agostinis, Aitziber Buqué Martinez, Timothy A. Chan, George Coukos, Sandra Demaria, Éric Deutsch, Dobrin Draganov, Richard L. Edelson, Silvia C. Formenti, Jitka Fučíková, Lucia Gabriele, Udo S. Gaipl, Sofia R. Gameiro, Abhishek D. Garg, Encouse B. Golden, Jian Han, Kevin J. Harrington, Akseli Hemminki, James W. Hodge, Dewan Md Sakib Hossain, Tim Illidge, Michael Karin, Howard L. Kaufman, Oliver Kepp, Guido Kroemer, Juan José Lasarte, Sherene Loi, Michael T. Lotze, Gwenola Manic, Taha Merghoub, Alan Melcher, Karen Mossman, Felipe Prósper, Øystein Rekdal, María Rescigno, Chiara Riganti, Antonella Sistigu, Mark J. Smyth, Radek Špíšek, John Stagg, Bryan E. Strauss, Daolin Tang, Kazuki Tatsuno, Stefaan Van Gool, Peter Vandenabeele, Takahiro Yamazaki, Dmitriy Zamarin, Laurence Zitvogel, Alessandra Cesano, Francesco M. Marincola - Journal for ImmunoTherapy of Cancer 2020 被引用: 1,061

  4. Type I interferons in anticancer immunity

    著者: Laurence Zitvogel, Lorenzo Galluzzi, Oliver Kepp, Mark J. Smyth, Guido Kroemer - Nature reviews. Immunology 2015 被引用: 1,301

  5. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

    著者: François Ghiringhelli, Lionel Apétoh, Antoine Tesnière, Laetitia Aymeric, Yuting Ma, Carla Ortiz, Karim Vermaelen, Theocharis Panaretakis, Grégoire Mignot, Evelyn Ullrich, Jean‐Luc Perfettini, F. Schlemmer, Ezgi Tasdemir, Martin Uhl, Pierre Génin, Ahmet Civas, Bernhard Ryffel, Jean Kanellopoulos, Jürg Tschopp, Fabrice André, Rosette Lidereau, Nicole M. McLaughlin, Nicole M. Haynes, Mark J. Smyth, Guido Kroemer, Laurence Zitvogel - Nature Medicine 2009 被引用: 1,836

  6. The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies

    著者: Tobias Bald, Matthew F. Krummel, Mark J. Smyth, Kevin C. Barry - Nature Immunology 2020 被引用: 496

  7. Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease

    著者: Jing Liu, Stephen J. Blake, Michelle C.R. Yong, Heidi Harjunpää, Shin Foong Ngiow, Kazuyoshi Takeda, Arabella Young, Jake S. O’Donnell, Stacey Allen, Mark J. Smyth, Michele W.L. Teng - Cancer Discovery 2016 被引用: 864

  8. Targeting immunosuppressive adenosine in cancer

    著者: Dipti Vijayan, Arabella Young, Michele W.L. Teng, Mark J. Smyth - Nature reviews. Cancer 2017 被引用: 797

  9. Myeloid immunosuppression and immune checkpoints in the tumor microenvironment

    著者: Kyohei Nakamura, Mark J. Smyth - Cellular and Molecular Immunology 2019 被引用: 515

  10. Translational biology of osteosarcoma

    著者: Maya Kansara, Michele W.L. Teng, Mark J. Smyth, David M. Thomas - Nature reviews. Cancer 2014 被引用: 1,316

  11. Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

    著者: Antonella Sistigu, Takahiro Yamazaki, Erika Vacchelli, Kariman Chaba, David Enot, Julien Adam, Ilio Vitale, Aïcha Goubar, Elisa Elena Baracco, Catarina Remédios, Laetitia Fend, Dalil Hannani, Laetitia Aymeric, Yuting Ma, Mireia Niso‐Santano, Oliver Kepp, Joachim L. Schultze, Thomas Tüting, Filippo Belardelli, Laura Bracci, Valentina La Sorsa, Giovanna Ziccheddu, Paola Sestili, Francesca Urbani, Mauro Delorenzi, Magali Lacroix‐Triki, Virginie Quidville, Rosa Conforti, Jean-Philippe Spano, Lajos Pusztai, Vichnou Poirier-Colame, Suzette Delaloge, Frédérique Penault‐Llorca, Sylvain Ladoire, Laurent Arnould, Joanna Cyrta, Marie-Charlotte Dessoliers, Alexander Eggermont, Marco E. Bianchi, Mikaël J. Pittet, Camilla Engblom, Christina Pfirschke, Xavier Préville, Gilles Uzé, Robert D. Schreiber, Melvyn T. Chow, Mark J. Smyth, Enrico Proietti, Fabrice André, Guido Kroemer, Laurence Zitvogel - Nature Medicine 2014 被引用: 1,031

  12. Natural Innate and Adaptive Immunity to Cancer

    著者: Matthew D. Vesely, Michael H. Kershaw, Robert D. Schreiber, Mark J. Smyth - Annual Review of Immunology 2011 被引用: 2,043

  13. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway

    著者: Sébastien Viel, Antoine Marçais, Fernando Guimarães, Róisín M. Loftus, Jessica Rabilloud, Morgan Grau, Sophie Degouve, Sophia Djebali, Amélien Sanlaville, Emily Charrier, Jacques Bienvenu, Julien C. Marie, Christophe Caux, Jacqueline Marvel, Liam Town, Nicholas D. Huntington, Laurent Bartholin, David K. Finlay, Mark J. Smyth, Thierry Walzer - Science Signaling 2016 被引用: 640

  14. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

    著者: Hirokazu Matsushita, Matthew D. Vesely, Daniel C. Koboldt, Charles G. Rickert, Ravindra Uppaluri, Vincent Magrini, Cora D. Arthur, J. Michael White, Yee-Shiuan Chen, Lauren Shea, Jasreet Hundal, Michael C. Wendl, Ryan Demeter, Todd Wylie, James P. Allison, Mark J. Smyth, Lloyd J. Old, Elaine R. Mardis, Robert D. Schreiber - Nature 2012 被引用: 1,297

  15. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases

    著者: Michele W.L. Teng, Edward P. Bowman, Joshua McElwee, Mark J. Smyth, Jean‐Laurent Casanova, Andrea M. Cooper, Daniel J Cua - Nature Medicine 2015 被引用: 857

  16. Classifying Cancers Based on T-cell Infiltration and PD-L1

    著者: Michele W.L. Teng, Shin Foong Ngiow, Antoni Ribas, Mark J. Smyth - Cancer Research 2015 被引用: 1,449

  17. Targeting natural killer cells in cancer immunotherapy

    著者: Camille Guillerey, Nicholas D. Huntington, Mark J. Smyth - Nature Immunology 2016 被引用: 1,081

  18. Control of Metastasis by NK Cells

    著者: Alejandro López‐Soto, Segundo González, Mark J. Smyth, Lorenzo Galluzzi - Cancer Cell 2017 被引用: 742

  19. New insights into cancer immunoediting and its three component phases — elimination, equilibrium and escape

    著者: Deepak Mittal, Matthew M. Gubin, Robert D. Schreiber, Mark J. Smyth - Current Opinion in Immunology 2014 被引用: 1,452

  20. Clinical relevance of host immunity in breast cancer: from TILs to the clinic

    著者: Peter Savas, Roberto Salgado, Carsten Denkert, Christos Sotiriou, Phillip K. Darcy, Mark J. Smyth, Sherene Loi - Nature Reviews Clinical Oncology 2015 被引用: 904

  21. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells

    著者: Yulong Gao, Fernando Souza-Fonseca-Guimarães, Tobias Bald, Susanna S. Ng, Arabella Young, Shin Foong Ngiow, Jai Rautela, Jasmin Straube, Nicola Waddell, Stephen J. Blake, Juming Yan, Laurent Bartholin, Jason S. Lee, Éric Vivier, Kazuyoshi Takeda, Meriem Messaoudene, Laurence Zitvogel, Michele W.L. Teng, Gabrielle T. Belz, Christian Engwerda, Nicholas D. Huntington, Kyohei Nakamura, Michael Hölzel, Mark J. Smyth - Nature Immunology 2017 被引用: 640

  22. Targeting CD39 in cancer

    著者: Achim K. Moesta, Xian-Yang Li, Mark J. Smyth - Nature reviews. Immunology 2020 被引用: 328

  23. Combination cancer immunotherapies tailored to the tumour microenvironment

    著者: Mark J. Smyth, Shin Foong Ngiow, Antoni Ribas, Michele W.L. Teng - Nature Reviews Clinical Oncology 2015 被引用: 976

  24. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

    著者: Sherene Loi, Stefan Michiels, Roberto Salgado, Nicolas Sirtaine, Vinu José, Debora Fumagalli, Pirkko Kellokumpu‐Lehtinen, Petri Bono, Vesa Kataja, Christine Desmedt, Martine Piccart, Sibylle Loibl, Carsten Denkert, Mark J. Smyth, Heikki Joensuu, Christos Sotiriou - Annals of Oncology 2014 被引用: 1,270